CRISPR Therapeutics AG Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG for May 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 25,923 | 46,921 | 118,093 | |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 24,077 | 43,579 | 144,016 | |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.03 | 25,923 | 415,577 | 1,215,005 | 1.2 M to 1.2 M (-2.09 %) |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 25,923 | 46,921 | 1,240,928 | 1.2 M to 1.2 M (+2.13 %) |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.50 | 24,077 | 397,283 | 1,215,005 | 1.2 M to 1.2 M (-1.94 %) |
| May 18 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 24,077 | 43,579 | 1,239,082 | 1.2 M to 1.2 M (+1.98 %) |
| May 09 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 616 | 1,115 | 168,093 | |
| May 09 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.92 | 616 | 10,426 | 1,215,005 | 1.2 M to 1.2 M (-0.05 %) |
| May 09 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 616 | 1,115 | 1,215,621 | 1.2 M to 1.2 M (+0.05 %) |
| May 05 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Please See Remarks | Option Exercise | A | 16.21 | 100,000 | 1,621,000 | 100,000 | |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 13,191 | 23,876 | 168,709 | |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 20,269 | 36,687 | 181,900 | |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Option Exercise | M | 1.81 | 50,000 | 90,500 | 202,169 | |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.37 | 13,191 | 215,960 | 1,215,005 | 1.2 M to 1.2 M (-1.07 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 13,191 | 23,876 | 1,229,196 | 1.2 M to 1.2 M (+1.08 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.64 | 1,022 | 17,003 | 1,215,005 | 1.2 M to 1.2 M (-0.08 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.05 | 19,247 | 308,984 | 1,216,027 | 1.2 M to 1.2 M (-1.56 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 20,269 | 36,687 | 1,235,274 | 1.2 M to 1.2 M (+1.67 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Sell | S | 16.53 | 15,924 | 263,236 | 1,215,005 | 1.2 M to 1.2 M (-1.29 %) |
| May 04 2017 | CRSP | CRISPR Therapeutic ... | Novak Rodger | Chief Executive Off ... | Buy | M | 1.81 | 15,924 | 28,822 | 1,230,929 | 1.2 M to 1.2 M (+1.31 %) |
| May 03 2017 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Sell | S | 16.61 | 1,852 | 30,753 | 168,204 | 170.1 K to 168.2 K (-1.09 %) |